TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Dne Pharma AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
33,008
|
30,090
|
22,279 |
Financial expenses |
1,525
|
1,490
|
11,629 |
Earnings before taxes |
6,049
|
4,686
|
-9,929 |
Total assets |
64,630
|
56,419
|
54,424 |
Current assets |
29,010
|
25,297
|
14,206 |
Current liabilities |
20,935
|
15,076
|
18,433 |
Equity capital |
37,345
|
34,317
|
29,216 |
- share capital |
100
|
106
|
100 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
57.8%
|
60.8%
|
53.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
18.3%
|
15.6%
|
-44.6% |
Return on assets (ROA) |
11.7%
|
10.9%
|
3.1% |
Current ratio |
138.6%
|
167.8%
|
77.1% |
Return on equity (ROE) |
16.2%
|
13.7%
|
-34.0% |
Change turnover |
4,499
|
6,610
|
2,351 |
Change turnover % |
16%
|
28%
|
12% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.